| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Nov―07 |
Refining the predictive utility of aspartate aminotransferase to platelet ratio index in nonalcoholic fatty liver disease patients with COVID-19 |
Kengo Matsumoto, Tsutomu Nishida |
| 2 |
[GO] |
2024―Feb―03 |
Impact of the COVID-19 pandemic on the number and short-term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018-2021 |
Yusuke Takemura, Hideki Endo, Taizo Hibi, Yutaka Nakano, Ryo Seishima, Masashi Takeuchi, et al. (+9) Hiroyuki Yamamoto, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa |
| 3 |
[GO] |
2024―Feb―01 |
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study |
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, et al. (+23) Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga-Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka |
| 4 |
[GO] |
2023―Nov―21 |
The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan - a multicenter collaborative observational study |
Kazuhiro Murai, Hayato Hikita, Takahiro Kodama, Masaki Kaibori, Yuki Nishimura, Tomohide Tatsumi, et al. (+4) Tomomi Yamada, Tatsuya Kanto, Satoshi Mochida, Tetsuo Takehara |
| 5 |
[GO] |
2023―Nov―03 |
Hepatic steatosis and skeletal muscle alterations during the COVID-19 lockdown in a cohort of patients with chronic liver disease in Japan |
Akira Uchiyama, Kazuyoshi Kon, Satoshi Sakuma, Toshifumi Sato, Maki Morinaga, Hiroo Fukada, et al. (+6) Hisafumi Yamagata, Reiko Yaginuma, Kyoko Fukuhara, Shunhei Yamashina, Shuko Nojiri, Kenichi Ikejima |
| 6 |
[GO] |
2023―Jul―20 |
APRI has Utility as a Biomarker of COVID-19 Severity in Patients with Nonalcoholic Fatty Liver Disease |
Hiroaki Takaya, Shunichi Ueyama, Yui Osaki, Kosuke Kaji, Hideto Kawaratani, Ko Saito, et al. (+6) Shigeyuki Aizawa, Tadashi Namisaki, Chie Morioka, Motoyuki Yoshida, Takemi Akahane, Hitoshi Yoshiji |
| 7 |
[GO] |
2023―Jan―19 |
Successful pediatric liver transplantation case with a positive SARS-CoV-2 test at the time of transplant: A case report and literature review |
Seiichi Shimizu, Seisuke Sakamoto, Masaki Yamada, Takanori Funaki, Akinari Fukuda, Hajime Uchida, et al. (+10) Noriki Okada, Toshimasa Nakao, Tasuku Kodama, Ryuji Komine, Kensuke Shoji, Chiaki Baba, Yasuyuki Suzuki, Satoshi Nakagawa, Chikara Ogimi, Mureo Kasahara |
| 8 |
[GO] |
2022―Jul―21 |
Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan |
Md Razeen Ashraf HUSSAIN, Lindsey HIEBERT, Aya SUGIYAMA, Serge OUOBA, Bunthen E, Ko KO, et al. (+5) Tomoyuki AKITA, Shuichi KANEKO, Tatsuya KANTO, John W. WARD, Junko TANAKA |
| 9 |
[GO] |
2021―Jul―14 |
Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases |
Reiichiro Kondo, Nao Kawaguchi, Matthew J. McConnell, Aurelio Sonzogni, Lisa Licini, Clarissa Valle, et al. (+10) Pietro A. Bonaffini, Sandro Sironi, Maria Grazia Alessio, Giulia Previtali, Michela Seghezzi, Xuchen Zhang, Zhaoli Sun, Teruo Utsumi, Mario Strazzabosco, Yasuko Iwakiri |
| 10 |
[GO] |
2020―Oct―13 |
The association of coagulopathy with liver dysfunction in patients with COVID-19 |
Takeya Tsutsumi, Makoto Saito, Hiroyuki Nagai, Shinya Yamamoto, Kazuhiko Ikeuchi, Lay Ahyoung Lim, et al. (+6) Eisuke Adachi, Michiko Koga, Kazuya Okushin, Hiroyuki Akai, Akira Kunimatsu, Hiroshi Yotsuyanagi |
| 11 |
[GO] |
2020―Aug―06 |
Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID-19 Patients with Pre-existing Chronic HBV Infection |
Jiaye Liu, Tingyan Wang, Qingxian Cai, Liqin Sun, Deliang Huang, Guangde Zhou, et al. (+4) Qing He, Fu-Sheng Wang, Lei Liu, Jun Chen |
| 12 |
[GO] |
2020―Jul―30 |
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19 |
Goki Suda, Koji Ogawa, Megumi Kimura, Osamu Maehara, Takashi Kitagataya, Masatsugu Ohara, et al. (+11) Yoshimasa Tokuchi, Akinori Kubo, Ren Yamada, Taku Shigesawa, Kazuharu Suzuki, Naoki Kawagishi, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Naoya Sakamoto |
| 13 |
[GO] |
2020―Jun―25 |
Treatment of Hepatocellular Carcinoma (HCC) during the COVID-19 Outbreak: The Working Group Report of JAMTT-HCC |
Masatoshi Kudo, Masayuki Kurosaki, Masafumi Ikeda, Hiroshi Aikata, Atsushi Hiraoka, Takuji Torimura, Naoya Sakamoto |
| 14 |
[GO] |
2020―May―09 |
Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies |
Mohammad Parohan, Sajad Yaghoubi, Asal Seraj |
|
